Ryan D Maynard

CIK 1363984 · Chief Financial Officer · last filed 2026-02-24

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.32M

Companies

5

Total Filings

39

Lifetime Open-Market Net

-$1.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FHTX Chief Financial Officer $4.18 $0 1 2026-02-24
IOVA Director 7,500 $4.08 $30.6K -$452.4K 11 2025-06-17
Tvardi Therapeutics, Inc. (CARA) Delisted CHIEF FINANCIAL OFFICER 8,012 $15.96 $127.9K -$2.9K 4 2024-02-12
RIGL EVP & CFO 100,000 $32.85 $3.29M -$1.45M 19 2017-11-07
IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted Director $0 3 2017-06-05

Recent Filings · Page 2 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-14 IOVA Grant (A) $0 EDGAR
2022-06-02 IOVA Buy (P) +7,500 $50.6K EDGAR
2021-07-01 IOVA Grant (A) $0 EDGAR
2020-06-10 IOVA Grant (A) $0 EDGAR
2019-06-11 IOVA Grant (A) $0 EDGAR
2018-07-19 IOVA Grant (A) $0 EDGAR
2017-11-07 RIGL Mixed -$176.0K EDGAR
2017-06-05 IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted Grant (A) $0 EDGAR
2017-04-21 RIGL Grant (A) $0 EDGAR
2017-02-06 RIGL Grant (A) $0 EDGAR
Showing 1120 of 39
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.